Osocimab (BAY-1213790)

From HemOnc.org - A Hematology Oncology Wiki
Revision as of 00:37, 29 July 2023 by Warner-admin (talk | contribs) (Warner-admin moved page Osocimab (BAY 1213790) to Osocimab (BAY-1213790) without leaving a redirect)
Jump to navigation Jump to search

Mechanism of action

Anti-Factor XIa antibody

Preliminary data

Venous thromboembolism

  1. FOXTROT: Weitz JI, Bauersachs R, Becker B, Berkowitz SD, Freitas MCS, Lassen MR, Metzig C, Raskob GE. Effect of Osocimab in Preventing Venous Thromboembolism Among Patients Undergoing Knee Arthroplasty: The FOXTROT Randomized Clinical Trial. JAMA. 2020 Jan 14;323(2):130-139. link to original article PubMed

Also known as

  • Code name: BAY-1213790
Retrieved from "https://hemonc.org/w/index.php?title=Osocimab_(BAY-1213790)&oldid=75859"